CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...